EP Patent

EP4088718A1 — Methods for treating coronaviridae virus infections

Assigned to Gilead Sciences Inc · Expires 2022-11-16 · 4y expired

What this patent protects

Provided are methods for treating Coronaviridae virus infections by administering nucleosides and prodrugs thereof, of Formula I:wherein the 1' position of the nucleoside sugar is substituted.

USPTO Abstract

Provided are methods for treating Coronaviridae virus infections by administering nucleosides and prodrugs thereof, of Formula I:wherein the 1' position of the nucleoside sugar is substituted.

Drugs covered by this patent

Patent Metadata

Patent number
EP4088718A1
Jurisdiction
EP
Classification
—
Expires
2022-11-16
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.